Phase – III trials of a vaccine for non-Hodgkin lymphoma gives hope to many patients

Non-Hodgkin lymphoma is a cancer arising from lymphocytes, a type of white blood cells. It is distinct from Hodgkin's disease, another subtype of lymphoma.

A company called Biovest International is now developing a vaccine for this disease and this vaccine is currently in its Phase-III trials in 24 medical institutions across the United States. This video throws more light on this subject.